CALL FOR ABSTRACTS NOW OPEN!

Deadline: December 1, 2026 at 11:59 p.m. ET

ORGANIZED BY

World Federation of Hemophilia

IN COLLABORATION WITH

Czech Society of Hemophilia

DESTINATION PARTNER

ORGANIZED BY
World Federation of Hemophilia

IN COLLABORATION WITH
Czech Society of Hemophilia

DESTINATION PARTNER
Prague Convention Bureau

ORGANIZED BY:
World Federation of Hemophilia

IN COLLABORATION WITH:
Czech Society of Hemophilia

DESTINATION PARTNER:
Prague Convention Bureau

Abstracts

Join us at the WFH 2027 Comprehensive Care Summit: New Developments in Bleeding Disorders and MSK, which will take place from April 14 to 16, 2027, in the vibrant city of Prague, Czechia. This global event will feature specialized tracks for MSK, medical professionals, and people with bleeding disorders, bringing together experts, patients, and advocates from around the world. This global summit is open to all participants.

CALL FOR ABSTRACTS

The call for abstract submissions to the WFH 2027 Comprehensive Care Summit (CCS) opens on September 15, 2026. The deadline to submit an abstract is December 1, 2026, 11:59 p.m. ET.

The CCS Program Committees invite researchers, healthcare professionals, and members of the bleeding disorders community to submit abstracts for oral and poster presentations at the summit taking place in Prague, Czechia, from April 14 to 16, 2027.

The 2027 scientific program will cover the latest research, developments and innovations in the field, from healthcare issues to the challenges ahead for the management and treatment of hemophilia, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders. This aspect of the summit—of bringing the best and brightest in our field together in one place—is critical to foster new ideas and approaches.

We encourage future delegates who would like to present their work at the summit, either orally or as a poster, to submit an abstract for consideration by the CCS Program Committees. All abstracts will be submitted to a blind peer review by an international panel of experts.

SUBMIT AN ABSTRACT

Submit an abstract

Submit your work today and join thousands of leading experts who are contributing to the latest advances in the treatment and care of people with bleeding disorders. To find out more about Haemophilia, the official journal of the WFH, please click here.

Questions? Contact us at [email protected].

Before submitting, please make sure to carefully read the abstract submission guidelines.

To submit your abstract

Step 1: Create your profile and login to access the Abstract Scorecard

Step 2: Complete all the tasks to submit your abstract

Step 3: Once completed, be sure to click submit

Editing a submission

You may edit your abstract after submitting it, up to the submission deadline of December 1, 2026.

To edit your abstract, log in to the Abstract Scorecard site to access your submission(s), where you will be able to make edits and changes.

Important notes:

Abstracts should only be submitted through the online system. Abstracts sent via post or email will not be considered.
Only abstracts which have been submitted properly will be considered. Incomplete abstracts will be automatically rejected.
Abstracts will only be accepted in English. Abstracts submitted in other languages will automatically be rejected.

KEY DATES
Call for abstracts opensSeptember 15, 2026
Abstract submission deadline

December 1, 2026, 11:59 p.m. ET

Notification to authorsDecember 31, 2026
Presenting author registration deadlineJanuary 31, 2027

BENEFITS OF SUBMITTING

The WFH CCS will feature specialized tracks for MSK, medical professionals, and people with bleeding disorders, bringing together experts, patients, and advocates from around the world. Presenting authors can expect to share their work with top experts and researchers from around the world.

Selected abstracts may be eligible for:

Publication in Haemophilia, the official journal of the WFH
Oral presentation in a free paper session
Printed poster and presentation during dedicated breaks
Christine Lee Young Researcher Award for best oral presentation and poster presentation (all disciplines)
Henri Horoszowski Award for best-scoring abstract (musculoskeletal track only)

We look forward to seeing you in Prague!

AWARDS

Christine Lee Young Researcher Award

All disciplines

Established in 2012 by the WFH and Wiley, the Christine Lee Young Researcher Award (formerly the Christine Lee Haemophilia Journal Award) is given in recognition to a top young researcher (graduate student or postdoctoral fellow) who is the primary author and presenter of a highly rated submitted abstract in any discipline involving hemophilia or other related bleeding disorders.

Best oral presentation

A prize of $3,000 USD and a three-year online personal subscription to Haemophilia is provided for this award.

Best poster presentation

A prize of $1,000 USD and a three-year online personal subscription to Haemophilia is provided for this award.

Eligibility

The selection committee, including the Journal’s editors and WFH representatives on the Editorial Board, will choose the best presented abstracts at the WFH 2027 CCS. There will be one recipient per prize.

The young researcher must be under the age of 40 at the time the abstract is submitted. If there are multiple authors, the lead author and presenter must be under the age of 40 at the time the abstract is submitted.

To find out more about the Christine Lee Young Researcher Award, click here. To find out more about Haemophilia, the official journal of the WFH, please click here.

Henri Horoszowski Award

Musculoskeletal field only

This award was established in 1998 to honour the memory of Professor Henri Horoszowski, former chairperson of the Musculoskeletal Committee, and to encourage musculoskeletal specialists to become involved in hemophilia care.

The presenters of any free paper in the musculoskeletal field selected for inclusion in the CCS 2027 are eligible for the award, with two exceptions:

  • Current or past members of the Musculoskeletal Committee
  • Previous winners of the award

Criteria for the award include scientific methodology, originality, relevance, and quality of the presentation as determined by a panel of judges appointed by the Musculoskeletal Committee.

To find out more about the Henri Horoszowski Award, click here. To find out more about Haemophilia, the official journal of the WFH, please click here.

ABSTRACTS FAQ

Q
How long should my abstract be?
A

Your abstract should be no longer than 350 words. This does not include the author’s details, titles, tables and graphs.

Q
Can I include tables/graphs in my abstract?
A

A maximum of two tables and/or graphs can be included in an abstract. Please make sure to add headings to each of the tables and/or graphs, and to reference them within the abstract. Please do NOT include the author list on the figure/table you are uploading, as we operate by blind review. Only Excel files will be accepted when uploading your tables/graphs.

Q
How many abstracts can I submit?
A

There is no limit to the number of abstracts a single author can submit.

Q
How many abstracts can I present?
A

Each presenting author may present a maximum of two abstracts at CCS. Should an author have more than two abstracts accepted, a co-author must be named as the presenting author for the third or more abstracts.

Q
Can I submit my abstract by email?
A

No. Abstracts should only be submitted through the online submission system. Abstracts sent via email will not be accepted.

Q
Can I submit an abstract in a language other than English?
A

No. Abstracts will only be accepted in written English. Abstracts submitted in any language other than English will be automatically rejected.

Q
How many authors can be listed for each submission?
A

A maximum of 20 authors is permitted on each abstract.

Q
Can I edit/make changes to my abstract?
A

Corrections can be made until the submission deadline of December 1, 2026. To ensure the integrity of the review process, no revisions will be allowed after the abstract submission deadline.

Q
Can I submit an abstract if I have presented it at another scientific meeting or submitted it to a journal?
A

Yes. The WFH accepts encore presentations. Encore abstracts should not be an exact duplicate of a previously presented abstract. Encore presentations will be considered for oral or poster presentations. They will not be published in the Haemophilia journal supplement.

Q
Can I submit a trial-in-progress abstract?
A

Yes. The WFH accepts abstracts in the category of “trial in progress”. Please consult the abstract submission guidelines for details.

Q
Can an administrator/third party submit an abstract on behalf of the authors?
A

Yes. However, note that if the abstract is accepted, all subsequent notifications and correspondence will be addressed to the presenting author.

Q
When will I know if my abstract has been accepted?
A

You will be notified no later than December 31, 2026.

Q
Do I need to register to attend CCS?
A

Yes. All presenting authors must register to attend CCS by January 31, 2027. After this date, presenting authors who have not registered and paid their registration fees will be excluded from the program as well as from the Haemophilia journal publication. Registration fees will not be waived.

Q
Can I present virtually?
A

No. CCS 2027 will take place in-person only. Presenting authors will therefore be required to be onsite in Prague, Czechia.

Q
When will my accepted abstract be published?
A

Abstracts selected for publication will be made available on the website of Haemophilia by April 14, 2027. The publication will be available on the Wiley website, the WFH CCS website, and the CCS mobile app.

Q
Will the WFH be accepting late-breaking abstracts?
A

No. There will not be a call for late-breaking abstracts for CCS 2027.

Q
Is my submission subject to embargo? If so, when does the embargo lift?
A

All abstracts will be publicly released at 9:00 a.m. CEST on April 14, 2027, and will be made available online.

Do you have additional questions? Please contact us at [email protected].

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.